BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology. 2010;129:363-374. [PMID: 19922426 DOI: 10.1111/j.1365-2567.2009.03179.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 129] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Sepehri Z, Kiani Z, Alavian SM, Arababadi MK, Kennedy D. The link between TLR7 signaling and hepatitis B virus infection. Life Sci 2016;158:63-9. [PMID: 27373425 DOI: 10.1016/j.lfs.2016.06.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
2 Broering R, Montag M, Jiang M, Lu M, Sowa JP, Kleinehr K, Gerken G, Schlaak JF. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state. Int Immunol 2011;23:537-44. [PMID: 21750146 DOI: 10.1093/intimm/dxr048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
3 Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence. Cells 2019;8:E376. [PMID: 31027278 DOI: 10.3390/cells8040376] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
4 Getachew A, Hussain M, Huang X, Li Y. Toll-like receptor 2 signaling in liver pathophysiology. Life Sci 2021;284:119941. [PMID: 34508761 DOI: 10.1016/j.lfs.2021.119941] [Reference Citation Analysis]
5 Zhang M, Hu X, Li S, Lu C, Li J, Zong Y, Qi W, Yang H. Hepatoprotective effects of ethyl pyruvate against CCl4-induced hepatic fibrosis via inhibition of TLR4/NF-κB signaling and up-regulation of MMPs/TIMPs ratio. Clin Res Hepatol Gastroenterol 2018;42:72-81. [PMID: 28601590 DOI: 10.1016/j.clinre.2017.04.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bhandari S, Li R, Simón-Santamaría J, McCourt P, Johansen SD, Smedsrød B, Martinez-Zubiaurre I, Sørensen KK. Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages. BMC Mol Cell Biol 2020;21:85. [PMID: 33246411 DOI: 10.1186/s12860-020-00331-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Akbal E, Koçak E, Köklü S, Ergül B, Akyürek Ö, Yılmaz FM. Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B. Viral Immunol 2017;30:278-82. [PMID: 28414577 DOI: 10.1089/vim.2016.0131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Stamm LV, Drapp RL. TLR2 and TLR4 mediate the TNFα response to Vibrio vulnificus biotype 1. Pathog Dis 2014;71:357-61. [PMID: 24532589 DOI: 10.1111/2049-632X.12154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Zheng XF, Hu XY, Ma B, Fang H, Zhang F, Mao YF, Yang FY, Xiao SC, Xia ZF. Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells. Front Pharmacol. 2018;9:959. [PMID: 30197594 DOI: 10.3389/fphar.2018.00959] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
10 Oosenbrug T, van de Graaff MJ, Ressing ME, van Kasteren SI. Chemical Tools for Studying TLR Signaling Dynamics. Cell Chem Biol 2017;24:801-12. [PMID: 28648377 DOI: 10.1016/j.chembiol.2017.05.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
11 Guerrero-Vargas NN, Guzmán-Ruiz M, Fuentes R, García J, Salgado-Delgado R, Basualdo Mdel C, Escobar C, Markus RP, Buijs RM. Shift Work in Rats Results in Increased Inflammatory Response after Lipopolysaccharide Administration: A Role for Food Consumption. J Biol Rhythms 2015;30:318-30. [PMID: 26017928 DOI: 10.1177/0748730415586482] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
12 Park SW, Kang JW, Lee SM. Role of Kupffer cells in ischemic injury in alcoholic fatty liver. J Surg Res. 2015;194:91-100. [PMID: 25438955 DOI: 10.1016/j.jss.2014.09.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
13 Yan H, Zhong M, Yang J, Guo J, Yu J, Yang Y, Ma Z, Zhao B, Zhang Y, Wang J, Wu C, Dittmer U, Yang D, Lu M, Zhang E, Yan H. TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells. Immunology 2020;161:325-44. [PMID: 32852795 DOI: 10.1111/imm.13251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gao Y, Song B, Aoki S, Ito K. Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice. EXCLI J 2020;19:387-99. [PMID: 32327959 DOI: 10.17179/excli2020-1103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol. 2011;55:762-769. [PMID: 21334391 DOI: 10.1016/j.jhep.2010.12.042] [Cited by in Crossref: 126] [Cited by in F6Publishing: 120] [Article Influence: 11.5] [Reference Citation Analysis]
16 Chen Y, Sun R. Toll-like receptors in acute liver injury and regeneration. Int Immunopharmacol. 2011;11:1433-1441. [PMID: 21601014 DOI: 10.1016/j.intimp.2011.04.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
17 Wunderlich F, Al-Quraishy S, Dkhil MA. Liver-inherent immune system: its role in blood-stage malaria. Front Microbiol 2014;5:559. [PMID: 25408684 DOI: 10.3389/fmicb.2014.00559] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
18 Campisano S, La Colla A, Echarte SM, Chisari AN. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutr Res Rev 2019;32:128-45. [PMID: 30707092 DOI: 10.1017/S0954422418000239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wilson CL, Mann J, Walsh M, Perrugoria MJ, Oakley F, Wright MC, Brignole C, Di Paolo D, Perri P, Ponzoni M, Karin M, Mann DA. Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3. PLoS One 2014;9:e83391. [PMID: 24416163 DOI: 10.1371/journal.pone.0083391] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
20 Huang S, Wu J, Gao X, Zou S, Chen L, Yang X, Sun C, Du Y, Zhu B, Li J, Yang X, Feng X, Wu C, Shi C, Wang B, Lu Y, Liu J, Zheng X, Gong F, Lu M, Yang D. LSECs express functional NOD1 receptors: A role for NOD1 in LSEC maturation-induced T cell immunity in vitro. Mol Immunol 2018;101:167-75. [PMID: 29944986 DOI: 10.1016/j.molimm.2018.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Beuke K, Schildberg FA, Pinna F, Albrecht U, Liebe R, Bissinger M, Schirmacher P, Dooley S, Bode JG, Knolle PA, Kummer U, Breuhahn K, Sahle S. Quantitative and integrative analysis of paracrine hepatocyte activation by nonparenchymal cells upon lipopolysaccharide induction. FEBS J 2017;284:796-813. [PMID: 28109179 DOI: 10.1111/febs.14022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Zhang E, Lu M. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection. Med Microbiol Immunol. 2015;204:11-20. [PMID: 25550115 DOI: 10.1007/s00430-014-0370-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 7.8] [Reference Citation Analysis]
23 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Huang S, Zou S, Chen M, Gao X, Chen L, Yang X, Yu Q, Zhao X, Du Y, Yang X, Lin Y, Wang B, Lu Y, Liu J, Zheng X, Gong F, Lu M, Yang D, Wu J. Local Stimulation of Liver Sinusoidal Endothelial Cells with a NOD1 Agonist Activates T Cells and Suppresses Hepatitis B Virus Replication in Mice. J Immunol 2018;200:3170-9. [PMID: 29592964 DOI: 10.4049/jimmunol.1700921] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
25 Williams JB, Hüppner A, Mulrooney-Cousins PM, Michalak TI. Differential Expression of Woodchuck Toll-Like Receptors 1-10 in Distinct Forms of Infection and Stages of Hepatitis in Experimental Hepatitis B Virus Infection. Front Microbiol 2018;9:3007. [PMID: 30581424 DOI: 10.3389/fmicb.2018.03007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol 2018;9:2640. [PMID: 30505304 DOI: 10.3389/fimmu.2018.02640] [Cited by in Crossref: 135] [Cited by in F6Publishing: 125] [Article Influence: 33.8] [Reference Citation Analysis]
27 Sørensen KK, Simon‐santamaria J, Mccuskey RS, Smedsrød B. Liver Sinusoidal Endothelial Cells. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1751-74. [DOI: 10.1002/cphy.c140078] [Cited by in Crossref: 119] [Cited by in F6Publishing: 112] [Article Influence: 17.0] [Reference Citation Analysis]
28 Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells 2020;9:E929. [PMID: 32290100 DOI: 10.3390/cells9040929] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
29 Minor T, von Horn C, Paul A. Role of erythrocytes in short-term rewarming kidney perfusion after cold storage. Artif Organs 2019;43:584-92. [PMID: 30511774 DOI: 10.1111/aor.13403] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
30 Pandey E, Nour AS, Harris EN. Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease. Front Physiol 2020;11:873. [PMID: 32848838 DOI: 10.3389/fphys.2020.00873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ibrahim SH. Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications. Am J Physiol Gastrointest Liver Physiol 2021;321:G67-74. [PMID: 34037463 DOI: 10.1152/ajpgi.00009.2021] [Reference Citation Analysis]
32 Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol. 2012;590:447-458. [PMID: 22124143 DOI: 10.1113/jphysiol.2011.219691] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 21.6] [Reference Citation Analysis]
33 Tripathi DM, Rohilla S, Kaur I, Siddiqui H, Rawal P, Juneja P, Kumar V, Kumari A, Naidu VGM, Ramakrishna S, Banerjee S, Puria R, Sarin SK, Kaur S. Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH. Int J Mol Sci 2021;22:8489. [PMID: 34445195 DOI: 10.3390/ijms22168489] [Reference Citation Analysis]
34 Khalique A, Zeng D, Wang H, Qing X, Zhou Y, Xin J, Zeng Y, Pan K, Shu G, Jing B, Shoaib M, Naqash, Ni X. Transcriptome analysis revealed ameliorative effect of probiotic Lactobacillus johnsonii BS15 against subclinical necrotic enteritis induced hepatic inflammation in broilers. Microb Pathog 2019;132:201-7. [PMID: 31077753 DOI: 10.1016/j.micpath.2019.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun 2015;21:827-46. [DOI: 10.1177/1753425915606525] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 15.9] [Reference Citation Analysis]
36 Sokolova V, Shi Z, Huang S, Du Y, Kopp M, Frede A, Knuschke T, Buer J, Yang D, Wu J, Westendorf AM, Epple M. Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulation. Acta Biomater 2017;64:401-10. [PMID: 28963016 DOI: 10.1016/j.actbio.2017.09.037] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
37 Manzoor S, Khalil S, Malik MA, Shafique K, Gul S, Javed F. Induction of Profibrotic Microenvironment via TLR4 MyD88-Dependent and -Independent Inflammatory Signaling in Chronic Hepatitis C Virus Infection. Viral Immunol 2020;33:585-93. [PMID: 32808884 DOI: 10.1089/vim.2019.0175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zhang E, Ma Z, Li Q, Yan H, Liu J, Wu W, Guo J, Zhang X, Kirschning CJ, Xu H, Lang PA, Yang D, Dittmer U, Yan H, Lu M. TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity. J Immunol 2019;203:2872-86. [PMID: 31636238 DOI: 10.4049/jimmunol.1900065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
39 Fisher JE, McKenzie TJ, Lillegard JB, Yu Y, Juskewitch JE, Nedredal GI, Brunn GJ, Yi ES, Malhi H, Smyrk TC, Nyberg SL. Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure. J Surg Res 2013;180:147-55. [PMID: 23260383 DOI: 10.1016/j.jss.2012.11.051] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
40 Szentirmai É, Massie AR, Kapás L. Lipoteichoic acid, a cell wall component of Gram-positive bacteria, induces sleep and fever and suppresses feeding. Brain Behav Immun 2021;92:184-92. [PMID: 33307170 DOI: 10.1016/j.bbi.2020.12.008] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Pinna F, Bissinger M, Beuke K, Huber N, Longerich T, Kummer U, Schirmacher P, Sahle S, Breuhahn K. A20/TNFAIP3 Discriminates Tumor Necrosis Factor (TNF)-Induced NF-κB from JNK Pathway Activation in Hepatocytes. Front Physiol 2017;8:610. [PMID: 28878689 DOI: 10.3389/fphys.2017.00610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
42 Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci 2020;21:E8351. [PMID: 33171747 DOI: 10.3390/ijms21218351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
43 Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells - partnering up with the immune system? Nat Rev Immunol 2022. [PMID: 35288707 DOI: 10.1038/s41577-022-00694-4] [Reference Citation Analysis]
44 Rojas-sánchez L, Zhang E, Sokolova V, Zhong M, Yan H, Lu M, Li Q, Yan H, Epple M. Genetic immunization against hepatitis B virus with calcium phosphate nanoparticles in vitro and in vivo. Acta Biomaterialia 2020;110:254-65. [DOI: 10.1016/j.actbio.2020.04.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
45 Xing Y, Zhao T, Gao X, Wu Y. Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury. Sci Rep 2016;6:21309. [PMID: 26887957 DOI: 10.1038/srep21309] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
46 Koetting M, Lüer B, Efferz P, Paul A, Minor T. Optimal Time for Hypothermic Reconditioning of Liver Grafts by Venous Systemic Oxygen Persufflation in a Large Animal Model. Transplantation 2011;91:42-7. [DOI: 10.1097/tp.0b013e3181fed021] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
47 Shi H, Dong L, Dang X, Liu Y, Jiang J, Wang Y, Lu X, Guo X. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm Res. 2013;62:581-587. [PMID: 23483217 DOI: 10.1007/s00011-013-0610-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
48 Sepulveda-Crespo D, Resino S, Martinez I. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants. Vaccines (Basel) 2020;8:E313. [PMID: 32560440 DOI: 10.3390/vaccines8020313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
49 van Golen RF, Reiniers MJ, Olthof PB, van Gulik TM, Heger M. Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics. J Gastroenterol Hepatol 2013;28:394-400. [PMID: 23216461 DOI: 10.1111/jgh.12072] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
50 Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol 2016; 8(32): 1354-1369 [PMID: 27917262 DOI: 10.4254/wjh.v8.i32.1354] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
51 Dhaiban S, Al-ani M, Elemam NM, Al-aawad MH, Al-rawi Z, Maghazachi AA. Role of Peripheral Immune Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Sci 2021;3:12. [DOI: 10.3390/sci3010012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Aravalli RN, Steer CJ. Immune-Mediated Therapies for Liver Cancer. Genes (Basel) 2017;8:E76. [PMID: 28218682 DOI: 10.3390/genes8020076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
53 Elbrolosy AM, Elabd NS, ElGedawy GA, Abozeid M, Abdelkreem M, Montaser B, Eed EM, Elhamouly MS. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients. Clin Exp Med 2022. [PMID: 35119591 DOI: 10.1007/s10238-022-00792-6] [Reference Citation Analysis]
54 Simon-Santamaria J, Rinaldo CH, Kardas P, Li R, Malovic I, Elvevold K, McCourt P, Smedsrød B, Hirsch HH, Sørensen KK. Efficient uptake of blood-borne BK and JC polyomavirus-like particles in endothelial cells of liver sinusoids and renal vasa recta. PLoS One. 2014;9:e111762. [PMID: 25375646 DOI: 10.1371/journal.pone.0111762] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
55 Cornide-Petronio ME, Álvarez-Mercado AI, Jiménez-Castro MB, Peralta C. Current Knowledge about the Effect of Nutritional Status, Supplemented Nutrition Diet, and Gut Microbiota on Hepatic Ischemia-Reperfusion and Regeneration in Liver Surgery. Nutrients 2020;12:E284. [PMID: 31973190 DOI: 10.3390/nu12020284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
56 Giugliano S, Kriss M, Golden-Mason L, Dobrinskikh E, Stone AE, Soto-Gutierrez A, Mitchell A, Khetani SR, Yamane D, Stoddard M, Li H, Shaw GM, Edwards MG, Lemon SM, Gale M Jr, Shah VH, Rosen HR. Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology 2015;148:392-402.e13. [PMID: 25447848 DOI: 10.1053/j.gastro.2014.10.040] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 8.5] [Reference Citation Analysis]
57 Hösel M, Quasdorff M, Ringelhan M, Kashkar H, Debey-Pascher S, Sprinzl MF, Bockmann JH, Arzberger S, Webb D, von Olshausen G, Weber A, Schultze JL, Büning H, Heikenwalder M, Protzer U. Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cell Mol Gastroenterol Hepatol 2017;4:339-63. [PMID: 28884137 DOI: 10.1016/j.jcmgh.2017.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
58 Real CI, Werner M, Paul A, Gerken G, Schlaak JF, Vaillant A, Broering R. Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells. Sci Rep. 2017;7:43838. [PMID: 28272460 DOI: 10.1038/srep43838] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
59 Lanthier N, Molendi-Coste O, Cani PD, van Rooijen N, Horsmans Y, Leclercq IA. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 2011;25:4301-4311. [PMID: 21873555 DOI: 10.1096/fj.11-189472] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
60 Liu LM, Liang DY, Zhang FF, Yu FP, Zhao L, Ye CG. Expression and role of Urotensin Ⅱ in lipopolysaccharide/D-galactosamine-induced acute liver failure in mice. Shijie Huaren Xiaohua Zazhi 2012; 20(18): 1616-1622 [DOI: 10.11569/wcjd.v20.i18.1616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. 2018;15:555-567. [PMID: 29844586 DOI: 10.1038/s41575-018-0020-y] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 30.3] [Reference Citation Analysis]
62 Sadik NAH, Shaker OG, Ghanem HZ, Hassan HA, Abdel-hamid AZ. Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients. Arch Virol 2015;160:2181-95. [DOI: 10.1007/s00705-015-2493-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
63 Tian Y, Chen WL, Ou JH. Effects of interferon-α/β on HBV replication determined by viral load. PLoS Pathog 2011;7:e1002159. [PMID: 21829354 DOI: 10.1371/journal.ppat.1002159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
64 Czaja AJ. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol 2016; 22(42): 9257-9278 [PMID: 27895415 DOI: 10.3748/wjg.v22.i42.9257] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
65 Soto-Tinoco E, Guerrero-Vargas NN, Buijs RM. Interaction between the hypothalamus and the immune system. Exp Physiol 2016;101:1463-71. [PMID: 27753158 DOI: 10.1113/EP085560] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
66 Sørensen KK, McCourt P, Berg T, Crossley C, Le Couteur D, Wake K, Smedsrød B. The scavenger endothelial cell: a new player in homeostasis and immunity. Am J Physiol Regul Integr Comp Physiol 2012;303:R1217-30. [PMID: 23076875 DOI: 10.1152/ajpregu.00686.2011] [Cited by in Crossref: 116] [Cited by in F6Publishing: 109] [Article Influence: 11.6] [Reference Citation Analysis]
67 Broering R, Real CI, John MJ, Jahn-Hofmann K, Ickenstein LM, Kleinehr K, Paul A, Gibbert K, Dittmer U, Gerken G, Schlaak JF. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro. Int Immunol 2014;26:35-46. [PMID: 24065781 DOI: 10.1093/intimm/dxt040] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
68 DeLeve LD, Maretti-Mira AC. Liver Sinusoidal Endothelial Cell: An Update. Semin Liver Dis 2017;37:377-87. [PMID: 29272898 DOI: 10.1055/s-0037-1617455] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
69 Robinson MW, Harmon C, O'Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol. 2016;13:267-276. [PMID: 27063467 DOI: 10.1038/cmi.2016.3] [Cited by in Crossref: 325] [Cited by in F6Publishing: 312] [Article Influence: 54.2] [Reference Citation Analysis]
70 Lopes JAG, Borges-Canha M, Pimentel-Nunes P. Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? World J Hepatol 2016; 8(3): 162-182 [PMID: 26839640 DOI: 10.4254/wjh.v8.i3.162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
71 Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14:996-1006. [PMID: 24048121 DOI: 10.1038/ni.2691] [Cited by in Crossref: 506] [Cited by in F6Publishing: 494] [Article Influence: 56.2] [Reference Citation Analysis]
72 Chi ZC. Intestinal microbiome and autoimmune liver disease. Shijie Huaren Xiaohua Zazhi 2019; 27(1): 50-62 [DOI: 10.11569/wcjd.v27.i1.50] [Reference Citation Analysis]
73 Øie CI, Snapkov I, Elvevold K, Sveinbjørnsson B, Smedsrød B. FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides. PLoS One 2016;11:e0160602. [PMID: 27494406 DOI: 10.1371/journal.pone.0160602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
74 Grant CR, Liberal R. Liver immunology: How to reconcile tolerance with autoimmunity. Clinics and Research in Hepatology and Gastroenterology 2017;41:6-16. [DOI: 10.1016/j.clinre.2016.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
75 Ye CG, Liang DY, Zhao L, Yu FP, Sun SL, Zhang JX, Liu LM. Rat Kupffer cells: Isolation, identification and LPS-stimulated TNF-α expression and secretion. Shijie Huaren Xiaohua Zazhi 2013; 21(4): 307-312 [DOI: 10.11569/wcjd.v21.i4.307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair. 2010;3:21. [PMID: 20964825 DOI: 10.1186/1755-1536-3-21] [Cited by in Crossref: 172] [Cited by in F6Publishing: 164] [Article Influence: 14.3] [Reference Citation Analysis]
77 Seki E, Park E, Fujimoto J. Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res 2011;41:597-610. [PMID: 21696522 DOI: 10.1111/j.1872-034X.2011.00822.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
78 Wu J, Huang S, Zhao X, Chen M, Lin Y, Xia Y, Sun C, Yang X, Wang J, Guo Y, Song J, Zhang E, Wang B, Zheng X, Schlaak JF, Lu M, Yang D. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model. J Virol 2014;88:10421-31. [PMID: 24920792 DOI: 10.1128/JVI.00996-14] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
79 Morgan E. Regulation of Drug-Metabolizing Enzymes and Drug Metabolism by Inflammatory Responses. Drug Metabolism in Diseases. Elsevier; 2017. pp. 21-58. [DOI: 10.1016/b978-0-12-802949-7.00002-x] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
80 Cacicedo ML, Medina-Montano C, Kaps L, Kappel C, Gehring S, Bros M. Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy. Cells 2020;9:E1985. [PMID: 32872352 DOI: 10.3390/cells9091985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Lin YJ, Wu HL, Chen DS, Chen PJ. Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice. J Virol. 2012;86:9266-9273. [PMID: 22718814 DOI: 10.1128/jvi.00608-12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
82 Gao M, Cai C, Han X, Wang L, Zhang W, Zhang L, Yang L. The early stage of pregnancy modulates toll-like receptor signaling in the ovine liver. Journal of Applied Animal Research 2021;49:374-81. [DOI: 10.1080/09712119.2021.1990935] [Reference Citation Analysis]
83 Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222-232. [PMID: 29379119 DOI: 10.1038/s41590-018-0044-z] [Cited by in Crossref: 281] [Cited by in F6Publishing: 289] [Article Influence: 70.3] [Reference Citation Analysis]
84 Rosen HR. Emerging concepts in immunity to hepatitis C virus infection. J Clin Invest. 2013;123:4121-4130. [PMID: 24084744 DOI: 10.1172/jci67714] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
85 Jiang M, Broering R, Trippler M, Wu J, Zhang E, Zhang X, Gerken G, Lu M, Schlaak JF. MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver. J Viral Hepat 2014;21:99-110. [PMID: 24383923 DOI: 10.1111/jvh.12126] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
86 Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013;87:1315-530. [PMID: 23974980 DOI: 10.1007/s00204-013-1078-5] [Cited by in Crossref: 751] [Cited by in F6Publishing: 687] [Article Influence: 83.4] [Reference Citation Analysis]
87 Minor T, Efferz P, Fox M, Wohlschlaeger J, Lüer B. Controlled oxygenated rewarming of cold stored liver grafts by thermally graduated machine perfusion prior to reperfusion. Am J Transplant. 2013;13:1450-1460. [PMID: 23617781 DOI: 10.1111/ajt.12235] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 10.2] [Reference Citation Analysis]
88 Lin Y, Gao ZX, Shen X, Chen MJ, Li YT, Li SL, Lin HL, Zhao QF, Liu F, Niu JJ. Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naïve patients: a case-control study in a Han Chinese population. BMC Infect Dis 2018;18:28. [PMID: 29320990 DOI: 10.1186/s12879-018-2943-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 Chaudhry S, Emond J, Griesemer A. Immune Cell Trafficking to the Liver. Transplantation 2019;103:1323-37. [PMID: 30817405 DOI: 10.1097/TP.0000000000002690] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
90 Zhang W, Wang L, Sun XH, Liu X, Xiao Y, Zhang J, Wang T, Chen H, Zhan YQ, Yu M, Ge CH, Li CY, Ren GM, Yin RH, Yang XM. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice. Mil Med Res 2021;8:16. [PMID: 33622404 DOI: 10.1186/s40779-021-00309-4] [Reference Citation Analysis]
91 Kriss M, Verna EC, Rosen HR, Lozupone CA. Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes. Transplantation 2019;103:668-78. [PMID: 30507741 DOI: 10.1097/TP.0000000000002568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Kim TH, Lee SH, Lee SM. Role of Kupffer cells in pathogenesis of sepsis-induced drug metabolizing dysfunction. FEBS J 2011;278:2307-17. [PMID: 21535472 DOI: 10.1111/j.1742-4658.2011.08148.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
93 Werner M, Schefczyk S, Trippler M, Treckmann JW, Baba HA, Gerken G, Schlaak JF, Broering R. Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3. Viruses 2022;14:218. [DOI: 10.3390/v14020218] [Reference Citation Analysis]
94 Bleau C, Filliol A, Samson M, Lamontagne L. Mouse Hepatitis Virus Infection Induces a Toll-Like Receptor 2-Dependent Activation of Inflammatory Functions in Liver Sinusoidal Endothelial Cells during Acute Hepatitis. J Virol. 2016;90:9096-9113. [PMID: 27489277 DOI: 10.1128/jvi.01069-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
95 Kim S, Lee S. Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition. Toxicology and Applied Pharmacology 2012;258:43-50. [DOI: 10.1016/j.taap.2011.10.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
96 Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol 2017;14:1017-9. [PMID: 29151579 DOI: 10.1038/cmi.2017.122] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
97 Bernsmeier C, Triantafyllou E, Brenig R, Lebosse FJ, Singanayagam A, Patel VC, Pop OT, Khamri W, Nathwani R, Tidswell R, Weston CJ, Adams DH, Thursz MR, Wendon JA, Antoniades CG. CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut 2018;67:1155-67. [PMID: 28592438 DOI: 10.1136/gutjnl-2017-314184] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
98 Bernsmeier C, van der Merwe S, Périanin A. Innate immune cells in cirrhosis. Journal of Hepatology 2020;73:186-201. [DOI: 10.1016/j.jhep.2020.03.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
99 Cabral F, Al-Rahem M, Skaggs J, Thomas TA, Kumar N, Wu Q, Fadda P, Yu L, Robinson JM, Kim J, Pandey E, Sun X, Jarjour WN, Rajaram MVS, Harris EN, Ganesan LP. Stabilin receptors clear LPS and control systemic inflammation. iScience 2021;24:103337. [PMID: 34816100 DOI: 10.1016/j.isci.2021.103337] [Reference Citation Analysis]
100 Yang L, Seki E. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front Physiol 2012;3:138. [PMID: 22661952 DOI: 10.3389/fphys.2012.00138] [Cited by in Crossref: 80] [Cited by in F6Publishing: 92] [Article Influence: 8.0] [Reference Citation Analysis]
101 Jiang L, Schnabl B. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda) 2020;35:261-74. [PMID: 32490750 DOI: 10.1152/physiol.00005.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
102 Hsieh YC, Lee KC, Wu PS, Huo TI, Huang YH, Hou MC, Lin HC. Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury. Cells 2021;10:1562. [PMID: 34205789 DOI: 10.3390/cells10061562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Jiang M, Broering R, Trippler M, Poggenpohl L, Fiedler M, Gerken G, Lu M, Schlaak JF. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen. J Viral Hepat. 2014;21:860-872. [PMID: 24498958 DOI: 10.1111/jvh.12216] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
104 Batista-duharte A, Portuondo D, Pérez O, Carlos IZ. Systemic immunotoxicity reactions induced by adjuvanted vaccines. International Immunopharmacology 2014;20:170-80. [DOI: 10.1016/j.intimp.2014.02.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
105 Furuta K, Guo Q, Hirsova P, Ibrahim SH. Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis. Biology (Basel) 2020;9:E395. [PMID: 33198153 DOI: 10.3390/biology9110395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Corbitt N, Kimura S, Isse K, Specht S, Chedwick L, Rosborough BR, Lunz JG, Murase N, Yokota S, Demetris AJ. Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantation. Am J Pathol 2013;182:180-91. [PMID: 23159949 DOI: 10.1016/j.ajpath.2012.09.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
107 Wilkinson AL, Qurashi M, Shetty S. The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver. Front Physiol 2020;11:990. [PMID: 32982772 DOI: 10.3389/fphys.2020.00990] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
108 Bartneck M, Warzecha KT, Tacke F. Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr. 2014;3:364-376. [PMID: 25568860 DOI: 10.3978/j.issn.2304-3881.2014.11.02] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
109 Liu J, Jiang M, Ma Z, Dietze KK, Zelinskyy G, Yang D, Dittmer U, Schlaak JF, Roggendorf M, Lu M. TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro. J Immunol. 2013;191:6178-6190. [PMID: 24227786 DOI: 10.4049/jimmunol.1301262] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
110 Wang L, Wang K, Zou ZQ. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World J Hepatol 2015; 7(30): 2980-2991 [PMID: 26730277 DOI: 10.4254/wjh.v7.i30.2980] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
111 Noureddin M, Zhang A, Loomba R. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opin Emerg Drugs 2016;21:343-57. [PMID: 27501374 DOI: 10.1080/14728214.2016.1220533] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
112 Kouroumalis E, Notas G. Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther 2015; 6(3): 32-58 [PMID: 26261733 DOI: 10.4292/wjgpt.v6.i3.32] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
113 Broering R, Lu M, Schlaak JF. Role of Toll-like receptors in liver health and disease. Clin Sci (Lond). 2011;121:415-426. [PMID: 21797822 DOI: 10.1042/cs20110065] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
114 Coelho I, Duarte N, Macedo MP, Penha-Gonçalves C. Insights into Macrophage/Monocyte-Endothelial Cell Crosstalk in the Liver: A Role for Trem-2. J Clin Med 2021;10:1248. [PMID: 33802948 DOI: 10.3390/jcm10061248] [Reference Citation Analysis]
115 Bagheri F, Khori V, Alizadeh AM, Khalighfard S, Khodayari S, Khodayari H. Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies. Life Sciences 2016;165:43-55. [DOI: 10.1016/j.lfs.2016.09.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
116 Movita D, Kreefft K, Biesta P, van Oudenaren A, Leenen PJ, Janssen HL, Boonstra A. Kupffer cells express a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal macrophages. J Leukoc Biol. 2012;92:723-733. [PMID: 22685319 DOI: 10.1189/jlb.1111566] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
117 Abolarinwa BA, Ibrahim RB, Huang YH. Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer. Int J Mol Sci 2019;20:E4624. [PMID: 31540435 DOI: 10.3390/ijms20184624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
118 Lan T, Wei Z, He Y, Wan S, Liu L, Cheng B, Li R, Chen H, Liu G, Meng Z. Immunostimulatory siRNA with a uridine bulge leads to potent inhibition of HBV and activation of innate immunity. Virol J 2021;18:37. [PMID: 33602251 DOI: 10.1186/s12985-021-01509-z] [Reference Citation Analysis]
119 Zhang X, Kraft A, Broering R, Schlaak JF, Dittmer U, Lu M. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections. Expert Opin Drug Discov. 2012;7:597-611. [PMID: 22607384 DOI: 10.1517/17460441.2012.689281] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
120 Sun H, Feng J, Tang L. Function of TREM1 and TREM2 in Liver-Related Diseases. Cells 2020;9:E2626. [PMID: 33297569 DOI: 10.3390/cells9122626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
121 Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak JF, Roggendorf M, Lu M. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. J Hepatol. 2012;57:522-528. [PMID: 22617154 DOI: 10.1016/j.jhep.2012.05.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
122 Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virol J. 2014;11:22. [PMID: 24507433 DOI: 10.1186/1743-422x-11-22] [Cited by in Crossref: 79] [Cited by in F6Publishing: 49] [Article Influence: 9.9] [Reference Citation Analysis]
123 Guo Y, He Y, Zhang Y, Zhou Y, Qin Y, Fan C, Ji G, Zhang P, Jia Z. Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-Chronic Hepatitis B Liver Failure: A Case-Control Study. Medicine (Baltimore) 2015;94:e1501. [PMID: 26426612 DOI: 10.1097/MD.0000000000001501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
124 Zhou Z, Qi J, Yang D, Yang MS, Jeong H, Lim CW, Kim JW, Kim B. Exogenous activation of toll-like receptor 5 signaling mitigates acetaminophen-induced hepatotoxicity in mice. Toxicol Lett 2021;342:58-72. [PMID: 33571619 DOI: 10.1016/j.toxlet.2021.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Wu X, Tian Z. Gut-liver axis: gut microbiota in shaping hepatic innate immunity. Sci China Life Sci 2017;60:1191-6. [PMID: 28840534 DOI: 10.1007/s11427-017-9128-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
126 Lamb C, Arbuthnot P. Activating the innate immune response to counter chronic hepatitis B virus infection. Expert Opin Biol Ther 2016;16:1517-27. [PMID: 27603796 DOI: 10.1080/14712598.2016.1233962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
127 Meng Z, Zhang X, Pei R, Zhang E, Kemper T, Vollmer J, Davis HL, Glebe D, Gerlich W, Roggendorf M, Lu M. Combination therapy including CpG oligodeoxynucleotides and entecavir induces early viral response and enhanced inhibition of viral replication in a woodchuck model of chronic hepadnaviral infection. Antiviral Res. 2016;125:14-24. [PMID: 26585244 DOI: 10.1016/j.antiviral.2015.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
128 Bartneck M. Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis. Adv Drug Deliv Rev 2021;173:70-88. [PMID: 33774114 DOI: 10.1016/j.addr.2021.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Aravalli RN. Role of innate immunity in the development of hepatocellular carcinoma. World J Gastroenterol 2013; 19(43): 7500-7514 [PMID: 24282342 DOI: 10.3748/wjg.v19.i43.7500] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
130 Nakamoto N, Kanai T. Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol. 2014;5:221. [PMID: 24904576 DOI: 10.3389/fimmu.2014.00221] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 9.0] [Reference Citation Analysis]
131 Meng Z, Chen Y, Lu M. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection. Front Immunol 2019;10:3127. [PMID: 32117201 DOI: 10.3389/fimmu.2019.03127] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
132 Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, Di Rosa F, Andrade R, Invernizzi P. Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models. Int J Mol Sci 2021;22:4557. [PMID: 33925355 DOI: 10.3390/ijms22094557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol. 2019;70:1278-1291. [PMID: 30797053 DOI: 10.1016/j.jhep.2019.02.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 22.7] [Reference Citation Analysis]
134 Wang XK, Peng ZG. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Front Pharmacol 2021;12:655557. [PMID: 33935770 DOI: 10.3389/fphar.2021.655557] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
135 Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28 Suppl 1:38-42. [PMID: 23855294 DOI: 10.1111/jgh.12019] [Cited by in Crossref: 147] [Cited by in F6Publishing: 150] [Article Influence: 18.4] [Reference Citation Analysis]
136 Xu F, Zhen P, Zheng Y, LIjuan F, Aiting Y, Min C, Hong Y, Jidong J. Preparation of Kupffer cell enriched non-parenchymal liver cells with high yield and reduced damage of surface markers by a modified method for flow cytometry. Cell Biol Int 2013;37:284-91. [PMID: 23348934 DOI: 10.1002/cbin.10035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]